Aptima®
Ref PRD-07881
Aptima (ASY-17189) is a SARS-CoV-2 nucleic acid IVD (EU IVDR Class B; FDA Class II; FDA product code QQX, Respiratory specimen nucleic acid SARS-CoV-2 test) made by Hologic, registered in EUDAMED on 9 Jul 2026 (Basic UDI-DI 54200455DIAGAPTSARSCOV2CC), cleared under FDA 510(k) K243396 on 13 Feb 2025 and listed in FDA GUDID since 14 Mar 2025 (UDI-DI 15420045516991), active as of 25 Oct 2026.
Active
CE IVDR 510(k)
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number54200455DIAGAPTSARSCOV2CC 15420045516991 | Date9 Jul 2026 | StatusActive |
| United States | GUDID listing GUDID | Number15420045516991 | Date14 Mar 2025 | StatusListed |
| United States | FDA 510(k)SESE GUDID | NumberK243396 | Date13 Feb 2025 | StatusActive |
Official records
- EUDAMED public site 54200455DIAGAPTSARSCOV2CC
- AccessGUDID record 15420045516991
- FDA 510(k) database K243396
From the FDA record
- Device description
- Aptima® SARS-CoV-2 Assay, 100 test, box 1 of 2 (2°C to 8°C box).
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI 54200455DIAGAPTSARSCOV2CC registered 9 Jul 2026 Active
- FDA 510(k) K243396 decided 13 Feb 2025 Active
- FDA GUDID UDI-DI 15420045516991 listed 14 Mar 2025 Listed
Timeline
- Cleared FDA 510(k) K243396
- Listed FDA GUDID 15420045516991
- Registered EUDAMED 54200455DIAGAPTSARSCOV2CC
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Aptima SARS-CoV-2 Assay EUDAMEDAptima® GUDID
- Generic name
- SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- PRD-07881 EUDAMEDBOX 1 GUDIDREFRIG GUDIDSARS-COV-2 ASSAY GUDIDAPTIMA 100T GUDIDIVD GUDIDASY-17189 GUDID
- Primary DI / UDI-DI
- 15420045516991
- Basic UDI-DI
- 54200455DIAGAPTSARSCOV2CC
- Direct marketing DI
- 15420045516991
- 510(k) Number
- FDA product code
- QQX
- EMDN code
- W0105041106 Coronavirus - na reagents
- GMDN term
- SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class B EUDAMEDClass II GUDID
- Regulation number
- 866.3981
- EU registration type
- Standard device
- EU market of registration
- Belgium
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Model / reference | PRD-07881 | BOX 1, REFRIG, SARS-COV-2 ASSAY, APTIMA 100T, IVD |
| Device class | Class B | Class II |
Similar devices in this category
Other devices filed under CORONAVIRUS - NA REAGENTS.
- ARMS-PCR Diagnostic Detection Kit for 2019-nCoV HV69-70del and N501Y mutation A9294YH by Beijing Applied Biological Technologies Co., Ltd.
- BD Respiratory Viral Panel for BD MAX™ System 445373 by Becton, Dickinson and Company
- Simplexa COVID-19 Direct MOL4150 by DiaSorin Molecular LLC
- Lyra Coronavirus M124 by DIAGNOSTIC HYBRIDS, INC.
- Truenat COVID-19 601430050 by Molbio Diagnostics Limited
- Helix Elite™ Molecular Standards: Inactivated Standard by MICROBIOLOGICS, INC.
- LyoSens SARS-CoV-2 qPCR Kit LYO106 by Vitrosens Biotechnology Inc.
- 2019-Novel Coronavirus, Influenza A and B virus nucleic acid test kit (Fluorescent Probe-based real-time PCR assay) R208T050B0C2 by Jiangsu Mole Bioscience Co., LTD.
- Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit (PCR-Fluorescence Probing) ZC-HX-201-3 by Shanghai BioGerm Medical Technology Co., Ltd.